/
/
/

Onesource Specialty Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
₹449 Cr₹428 Cr₹290 Cr₹376 Cr₹327 Cr₹426 Cr₹393 Cr₹334 Cr₹292 Cr₹73 Cr₹56 Cr₹34 Cr
₹4 Cr₹2 Cr₹5 Cr₹3 Cr₹5 Cr₹3 Cr₹7 Cr₹4 Cr₹4 Cr₹3 Cr₹1 Cr₹9 L
₹453 Cr₹430 Cr₹295 Cr₹379 Cr₹333 Cr₹429 Cr₹399 Cr₹338 Cr₹296 Cr₹76 Cr₹57 Cr₹34 Cr
₹397 Cr₹408 Cr₹343 Cr₹339 Cr₹307 Cr₹312 Cr₹319 Cr₹325 Cr₹296 Cr₹95 Cr₹86 Cr₹91 Cr
₹127 Cr₹94 Cr₹22 Cr₹110 Cr₹94 Cr₹185 Cr₹149 Cr₹82 Cr₹68 Cr-₹16 L-₹9 Cr-₹38 Cr
₹31 Cr₹23 Cr₹38 Cr₹34 Cr₹27 Cr₹33 Cr₹46 Cr₹45 Cr₹42 Cr₹20 Cr₹26 Cr₹25 Cr
₹20 Cr-₹29 L-₹93 Cr₹6 Cr-₹4 Cr₹84 Cr-₹67 Cr-₹37 Cr-₹47 Cr-₹40 Cr-₹161 Cr-₹87 Cr
₹25 Cr₹5 Cr-₹89 Cr₹10 Cr-₹19 L₹99 Cr-₹69 Cr-₹42 Cr-₹6 Cr-₹40 Cr-₹130 Cr-₹114 Cr

Share Price Live Stats

Open (₹)1,552.90
Volume (₹)1.40 L
High (₹)1,573.00
Upper Circuit1,845.30
Low (₹)1,530.00
Lower Circuit1,230.30
Prev Close1,537.80
52W High (₹)1,925.00
Price1,569.00
52W Low (₹)1,057.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)17587.40 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.22
Price to Book2.90
Book Value508.17
EPS (TTM)-4.24
Face Value1.00
ROE (%)-1.26

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
CIPLANSE
ZYDUSLIFENSE
LAURUSLABSNSE
LUPINNSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
ONESOURCENSE
LTP
1W Low
1W High
Market cap (₹)
1895-21 (-1.10%)
1883.10
1936.80
4,55,634Cr
9315+65 (0.70%)
9100
9315
2,41,576Cr
4914+8.5 (0.17%)
4823
5025
1,84,478Cr
1395+0.3 (0.02%)
1375.50
1415.40
1,11,888Cr
1156.9+13.9 (1.22%)
1114.10
1163
1,11,820Cr
1876.7+8.2 (0.44%)
1832.70
1876.70
99,418Cr
2105-27 (-1.27%)
2095.60
2159.90
96,529Cr
1144.2-10.8 (-0.94%)
1141.80
1166.80
96,322Cr
2318-50.8 (-2.14%)
2303.50
2390
96,180Cr
1660+22.7 (1.39%)
1622.60
1668
95,127Cr
1569-6.7 (-0.43%)
1526
1596.60
17,587Cr

Key Highlights of Onesource Specialty Pharma Ltd’s P&L

In 2026-03-31, Onesource Specialty Pharma Ltd reported total revenue of ₹1468.05Cr, compared with ₹1465.04Cr in 2025-03-31, reflecting Onesource Specialty Pharma Ltd turnover.

Depreciation was ₹279.09Cr and finance costs were ₹122.19Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹-₹91.96Cr in 2026-03-31 as compared to ₹-₹67.07Cr in 2025-03-31.

Net Profit (PAT) was ₹-₹73.8Cr in 2026-03-31 compared with ₹-₹17.97Cr in 2025-03-31.

Earnings per share (EPS) were ₹-6.44 in 2026-03-31, compared with ₹-1.57 in 2025-03-31.